Mariola Fotin-Mleczek
Chief Tech/Sci/R&D Officer presso CureVac SE
Profilo
La dott.ssa Mariola Fotin-Mleczek è Chief Technology Officer di CureVac AG e Chief Technology Officer di CureVac NV.
Posizioni attive di Mariola Fotin-Mleczek
| Società | Posizione | Inizio |
|---|---|---|
CureVac SE
 CureVac SE BiotechnologyHealth Technology CureVac SE engages in the development of tumor immunotherapy. Its pipeline include mRNA-based Cancer Immunotherapies; Protein-based therapies; and mRNA-based Prophylactic Vaccines. The company was founded by Ingmar Hoerr, Florian von der Mülbe, Hans Georg Rammensee, Günther Jung, and Steve Pascolo in 2000 and is headquartered in Tübingen, Germany. | Chief Tech/Sci/R&D Officer | 01/01/2013 |
Precedenti posizioni note di Mariola Fotin-Mleczek
| Società | Posizione | Fine |
|---|---|---|
| CUREVAC N.V. | Chief Tech/Sci/R&D Officer | 31/01/2022 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| CUREVAC N.V. | Health Technology |
| Aziende private | 1 |
|---|---|
CureVac SE
CureVac SE BiotechnologyHealth Technology CureVac SE engages in the development of tumor immunotherapy. Its pipeline include mRNA-based Cancer Immunotherapies; Protein-based therapies; and mRNA-based Prophylactic Vaccines. The company was founded by Ingmar Hoerr, Florian von der Mülbe, Hans Georg Rammensee, Günther Jung, and Steve Pascolo in 2000 and is headquartered in Tübingen, Germany. | Health Technology |
- Borsa valori
- Insiders
- Mariola Fotin-Mleczek
